Insider Transactions in Q4 2020 at Bluebird Bio, Inc. (BLUE)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2020
|
Katy Burnett Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
123
-7.77%
|
$5,658
$46.09 P/Share
|
|
Dec 02
2020
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
444
-0.23%
|
$20,424
$46.34 P/Share
|
|
Dec 02
2020
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
64
-0.08%
|
$2,944
$46.34 P/Share
|
|
Dec 02
2020
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
59
-0.08%
|
$2,714
$46.34 P/Share
|
|
Dec 02
2020
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
38
-0.05%
|
$1,748
$46.34 P/Share
|
|
Dec 02
2020
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
38
-0.09%
|
$1,748
$46.34 P/Share
|
|
Dec 02
2020
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
36
-0.07%
|
$1,656
$46.34 P/Share
|
|
Nov 02
2020
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
444
-0.15%
|
$23,532
$53.59 P/Share
|
|
Nov 02
2020
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
63
-0.05%
|
$3,339
$53.59 P/Share
|
|
Nov 02
2020
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
59
-0.05%
|
$3,127
$53.59 P/Share
|
|
Nov 02
2020
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
37
-0.03%
|
$1,961
$53.59 P/Share
|
|
Nov 02
2020
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
37
-0.06%
|
$1,961
$53.59 P/Share
|
|
Nov 02
2020
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
35
-0.04%
|
$1,855
$53.59 P/Share
|
|
Oct 02
2020
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
60
-0.17%
|
$3,120
$52.77 P/Share
|
|
Oct 02
2020
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
450
-0.45%
|
$23,400
$52.77 P/Share
|
|
Oct 02
2020
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
36
-0.13%
|
$1,872
$52.77 P/Share
|
|
Oct 02
2020
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
38
-0.17%
|
$1,976
$52.77 P/Share
|
|
Oct 02
2020
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
38
-0.11%
|
$1,976
$52.77 P/Share
|
|
Oct 02
2020
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
64
-0.16%
|
$3,328
$52.77 P/Share
|